Abstract:AIMS:As an emerging interventional technique to treat resistant hypertension, renal denervation (RDN) has also attracted considerable attention due to its potential beneficial effects on glucose and lipid metabolism. Given that inconsistent results were documented among studies, we aimed to perform a systematic review and meta-analysis to elaborate on this issue.METHODS:The PubMed, EMBASE, Web of Science (SCI) and ClinicalTrials.gov databases were comprehensively searched from their inception date to June 18, 2020, for relevant clinical studies evaluating the efficacy of RDN on glucose and lipid levels. The outcomes of interest were changes in fasting glucose, insulin, C-peptide, hemoglobin A1C (HbA1C), homeostatic model assessment-insulin resistance (HOMA-IR), cholesterol and triglyceride (TG) levels before versus after RDN and also RDN versus the control group. The mean differences (MDs) of the outcomes measured before versus after RDN and RDN versus the control group were pooled by a randomized effects model. Heterogeneity was quantified with Chi-square (χ2) and inconsistency index (I2). Assessment of publication bias was performed by the funnel plot and Egger's test.RESULTS:A total of 1600 studies were initially identified. Nineteen of the identified studies (six randomized controlled studies, one non-randomized controlled studies and 12 observational cohort studies) involving 2245 subjects were included in the final analysis. No significant change was observed after RDN in fasting glucose (weighted mean difference [WMD] - 0.19 mmol/L; 95% CI - 0.37, 0.00 mmol/L), insulin (standardized mean difference [SMD] - 0.01; 95% CI - 0.41, 0.39), C-peptide (SMD - 0.05; 95% CI - 0.30, 0.21), HbA1C (SMD - 0.05; 95% CI - 0.17, 0.07), HOMA-IR (SMD - 0.29; 95% CI - 0.72, 0.14), total cholesterol (TC) (WMD - 0.11 mmol/L; 95% CI - 0.37, 0.15 mmol/L), and low-density lipoprotein cholesterol (LDL-C) levels (WMD - 0.18 mmol/L; 95% CI - 0.59, 0.24 mmol/L) during follow-up. Changes in fasting glucose, insulin, HbA1C and TC levels in RDN groups were not significantly different from those in the control group. High-density lipoprotein cholesterol (HDL-C) and TG were slightly improved after RDN (WMD 0.07 mmol/L, 95% CI 0.01, 0.14 mmol/L; WMD - 0.26 mmol/l, 95% CI - 0.51, - 0.01 mmol/L, respectively). The funnel plot and Egger's test demonstrated the absence of potential publication bias.CONCLUSIONS:Catheter-based RDN appeared to have no impact on glucose metabolism. There was a statistically significant but clinically negligible improvement in HDL-C and TG levels based on the current evidence. Future research with more rigorous designs is warranted to draw definitive conclusions.REGISTRATION DETAILS:The protocol of this meta-analysis was registered on PROSPERO (CRD42020192805). ( https://www.crd.york.ac.uk/PROSPERO/display_record.php?RecordID=192805 ).

Renal Denervation Improves Vascular Endothelial Dysfunction by Inducing Autophagy Via AMPK/mTOR Signaling Activation in a Rat Model of Type 2 Diabetes Mellitus with Insulin Resistance

Beneficial effects of renal denervation on cardiac angiogenesis in rats with prolonged pressure overload.

Renal denervation ameliorates cardiac metabolic remodeling in diabetic cardiomyopathy rats by suppressing renal SGLT2 expression

Renal Denervation Significantly Attenuates Cardiorenal Fibrosis in Rats with Sustained Pressure Overload.

Renal Denervation Findings on Cardiac and Renal Fibrosis in Rats with Isoproterenol Induced Cardiomyopathy

Effects of Multi-Electrode Renal Denervation on Insulin Sensitivity and Glucose Metabolism in a Canine Model of Type 2 Diabetes Mellitus

Renal Denervation: A Potential Novel Treatment for Type 2 Diabetes Mellitus?

Improvement of Cardiac Dysfunction by Bilateral Surgical Renal Denervation in Animals with Diabetes Induced by High Fructose and High Fat Diet.

Renal denervation ameliorates atrial remodeling in type 2 diabetic rats by regulating mitochondrial dynamics

Renal Denervation Attenuates Pressure Overload‐induced Cardiac Remodelling in Rats with Biphasic Regulation of Autophagy

Renal Denervation Attenuates Multi-Organ Fibrosis and Improves Vascular Remodeling in Rats with Transverse Aortic Constriction Induced Cardiomyopathy.

Renal Denervation Attenuates Progression of Atherosclerosis in Apolipoprotein E–Deficient Mice Independent of Blood Pressure Lowering

Renal denervation improves mitochondrial oxidative stress and cardiac hypertrophy through inactivating SP1/BACH1-PACS2 signaling

Renal Denervation Attenuates Aldosterone Expression and Associated Cardiovascular Pathophysiology in Angiotensin II-induced Hypertension.

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion

Favorable effect of renal denervation on elevated renal vascular resistance in patients with resistant hypertension and type 2 diabetes mellitus

Renal denervation alleviates vascular remodeling in spontaneously hypertensive rats by regulating perivascular adipose tissue

Long-term Renal Sympathetic Denervation Ameliorates Renal Fibrosis and Delays the Onset of Hypertension in Spontaneously Hypertensive Rats

Catheter-Based Renal Denervation Attenuates Kidney Interstitial Fibrosis in a Canine Model of High-Fat Diet-Induced Hypertension

Renal Sympathetic Denervation Raises Blood Pressure And Attenuates Ventricular Remodeling In Rats With Myocardial Infarction

Effects of Catheter-Based Renal Denervation on Glycemic Control and Lipid Levels: a Systematic Review and Meta-Analysis